Indo-Bangla Pharmaceuticals (DHA:IBP) Other Current Liabilities: BDT0.00 Mil (As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT17.20
View Full Analysis

What is Indo-Bangla Pharmaceuticals Other Current Liabilities?

Indo-Bangla Pharmaceuticals DHA:IBP -2.82% 32 Other Current Liabilities is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Indo-Bangla Pharmaceuticals's other current liabilities for the quarter that ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Other Current Liabilities Related Terms

Indo-Bangla Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Other Current Liabilities Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Other Current Liabilities

Indo-Bangla Pharmaceuticals Semi-Annual Data
Other Current Liabilities
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of BDT0.00 Mil mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Other Current Liabilities of BDT0.00 Mil as of . 20. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Indo-Bangla Pharmaceuticals.
Is Indo-Bangla Pharmaceuticals' Other Current Liabilities too high?
Indo-Bangla Pharmaceuticals' current Other Current Liabilities is BDT0.00 Mil. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Other Current Liabilities compare to ?
Indo-Bangla Pharmaceuticals' Other Current Liabilities of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Indo-Bangla Pharmaceuticals. Indo-Bangla Pharmaceuticals's current Other Current Liabilities is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Other Current Liabilities of BDT0.00 Mil. The current Other Current Liabilities is BDT0.00 Mil. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Other Current Liabilities is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT17.20
Price